NFKB1 and non-small cell lung carcinoma: GA also inhibited the NF-κB and MAPK/HO-1 pathways to enhance apoptosis triggered by cisplatin (CDDP) in non-small-cell lung cancer (NSCLC) (Wang L. H. et al., 2014).